ArticleJournal of thoracic disease2025
Bronchodilator response as an independent predictor of severity in bronchiectasis.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bronchodilator response in bronchiectasis: mind the gap between definition and clinical reality.Journal of thoracic disease · 2026Article
- Pulmonary function and airflow limitation in bronchiectasis: a case-control study of two independent cohorts.BMJ open respiratory research · 2026Article
Corrections and comments
- Commented on by
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bronchodilator response (BDR) is occasionally observed in patients with bronchiectasis. However, clinical implications of BDR of bronchiectasis remain unclear. This multicenter observational cohort study aimed to compare clinical characteristics and severity in bronchiectasis between patients with BDR and without BDR. Methods: We collected data from the Korean Multicenter Bronchiectasis Audit and Research Collaboration (KMBARC) registry, a multicenter observational cohort of non-cystic fibrosis bronchiectasis. We reviewed the medical records of 709 patients who underwent spirometry. We defined BDR as forced expiratory volume in one second (FEV Results: Of the 709 patients, 7.3% exhibited BDR. Patients with BDR showed worse pulmonary function than those without BDR, both at baseline (FEV Conclusions: In bronchiectasis, BDR is associated with poorer lung function, more frequent exacerbation, and increased disease severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.